Stocks to buy

The stock market has roared back to life in 2023 and has largely outperformed expectations. Investors have begun to pour back into the stock market in search of bargains. However, despite high returns in growth stocks, investors are still highly interested in seeking lower-risk securities. A typical way to go about doing that is to
0 Comments
Artificial intelligence (AI) is a revolutionary technology that helps people access relevant information more quickly and increase their productivity. While OpenAI’s ChatGPT has taken center stage recently, many companies use AI in the background to improve their services and increase their revenue. Some high-potential AI stocks use this technology to make product recommendations, while other
0 Comments
Let’s take a quick look at stocks for investment until 2033. All are high-quality firms, meaning they’re stable and have the potential to continue growing. Granted, it might be hard to imagine some of these companies getting bigger. But that’s exactly what some detractors surely said a decade ago. The truth is that many of the best
0 Comments
When it comes to finding the best long-term dividend stocks to buy, yield should one be a key part of your overall criteria. It may sound tempting to build a dividend portfolio made up entirely of high-yielding names, but there are some flaws to such a strategy. Namely, given how common it is for high-yielding
0 Comments
In times of economic uncertainty, it can be wise to invest in recession-proof growth stocks that have the ability to withstand downturns and offer financial stability. Ensuring a portfolio is both robust and has growth potential is crucial. This piece spotlights three exceptional growth stocks that possess these attributes, effectively safeguarding against any potential economic
0 Comments
A Deloitte report about artificial intelligence (AI) in the life sciences puts it bluntly. Big data is the new currency for biopharma firms. The quantum leap forward in computational power that AI affords gives pharmaceutical firms the ability to develop products faster than ever before. This has lead investors to start looking for the top
0 Comments
When it comes to possibilities of outsized rewards, few sectors can beat out biotech stocks with blockbuster potential. Fundamentally, the underlying sector enjoys a massive footprint. According to Grand View Research, the global biotech market size reached a valuation of $1.37 trillion last year. However, the segment might expand at a compound annual growth rate (CAGR)
0 Comments